ETNK2/Ethanolamine kinase 2 Antibody, Cy5.5 Conjugated
Applications
Predicted Reactivity
Overview | |
Catalog # | bs-13112R-Cy5.5 |
Product Name | ETNK2/Ethanolamine kinase 2 Antibody, Cy5.5 Conjugated |
Applications | WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
Predicted Reactivity | Human, Mouse, Rat, Pig |
Specifications | |
Conjugation | Cy5.5 |
Host | Rabbit |
Source | KLH conjugated synthetic peptide derived from human ETNK2/Ethanolamine kinase 2 |
Immunogen Range | 21-120/386 |
Clonality | Polyclonal |
Isotype | IgG |
Concentration | 1ug/ul |
Purification | Purified by Protein A. |
Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target | |
Gene ID | 55224 |
Subcellular location | Cytoplasm |
Synonyms | 4933417N20Rik; AI197444; EC 2.7.1.82; EKI 2; EKI2; EKI2_HUMAN; Ethanolamine kinase 2; Ethanolamine kinase like protein; Ethanolamine kinase-like protein; ETNK 2; ETNK2; FLJ10761; HMFT1716; RP11 74C13.2; Tuc1. |
Background | Ethanolamine kinase 2, also known as EKI2, ETNK2 or HMFT1716, is a 386 amino acid protein that belongs to the choline/ethanolamine kinase family. Via the cytidine diphosphate (CDP) ethanolamine pathway, Ethanolamine kinase 2 catalyses the initial step of phosphatidylethanolamine (PtdEtn) biosynthesis. Ethanolamine kinase 2 is expressed in kidney, liver, testis, ovary and prostate, and is highly specific for ethanolamine phosphorylation. Upregulated during testis development, Ethanolamine kinase 2 may play an essential role in regulating placental hemostasis. Existing as three alternatively spliced isoforms, the gene encoding Ethanolamine kinase 2 maps to human and mouse chromosome 1. Human chromosome 1 spans 260 million base pairs, contains over 3,000 genes, comprises nearly 8% of the human genome and houses a large number of disease-associated genes, including those that are involved in familial adenomatous polyposis, Stickler syndrome, Parkinson?s disease, Gaucher disease, schizophrenia and Usher syndrome. |
Application Dilution | |
WB | 1:300-5000 |
IF(IHC-P) | 1:50-200 |
IF(IHC-F) | 1:50-200 |
IF(ICC) | 1:50-200 |